Swanson C et al. |
FK 506-based immunosuppression in clinical pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539827
|
Murase N et al. |
FK 506 prevents spontaneous diabetes in the BB rat. |
1991 |
Transplant. Proc. |
pmid:1703705
|
Watanabe K et al. |
Donor bone marrow cell facilitates induction of tolerance to kidney allografts in dogs treated with fractionated lymphoid irradiation and FK 506. |
1991 |
Transplant. Proc. |
pmid:1703706
|
Kobayashi N et al. |
Significance of pancreatic allograft rejection in swine abdominal organ cluster transplantation. |
1991 |
Transplant. Proc. |
pmid:1703707
|
Khalaf H et al. |
Tacrolimus (FK 506) given three times daily after liver transplantation for minimizing nephrotoxicity and neurotoxicity. |
2003 |
Transplant. Proc. |
pmid:14612120
|
Gamboa O et al. |
Cost-effectiveness analysis of the early conversion of tacrolimus to mammalian target of rapamycin inhibitors in patients with renal transplantation. |
2011 |
Transplant. Proc. |
pmid:22099798
|
Kumar MS et al. |
ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis. |
1998 |
Transplant. Proc. |
pmid:9636549
|
Yu L et al. |
Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation. |
2000 |
Transplant. Proc. |
pmid:11119902
|
Tang J et al. |
Cytokine Profile in Calcineurin Inhibitor-Induced Chronic Nephrotoxicity in Chinese Liver Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27788813
|
Corry RJ et al. |
Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients. |
1998 |
Transplant. Proc. |
pmid:9532157
|
Wasserberg N et al. |
Tacrolimus does not upregulate mucin gene expression after small bowel transplantation in rats. |
2003 |
Transplant. Proc. |
pmid:12644089
|
Fernández A et al. |
Complete switch to everolimus in long-term kidney transplants: evolution of the renal function. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715915
|
Alarcón-Zurita A et al. |
Steroids withdrawal after 3 months of successful renal transplantation using a tacrolimus- and mycophenolate-based immunosuppression. |
2002 |
Transplant. Proc. |
pmid:11959216
|
Hoffman AL et al. |
The effect of FK 506 on small intestine allotransplantation in the rat. |
1990 |
Transplant. Proc. |
pmid:1689907
|
Moochhala SM et al. |
Inhibition of drug metabolism in rat and human liver microsomes by FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721277
|
Pan F et al. |
Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models. |
1996 |
Transplant. Proc. |
pmid:8623373
|
Takada Y et al. |
Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. |
2000 |
Transplant. Proc. |
pmid:10715416
|
Land W et al. |
Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients. |
2001 |
Transplant. Proc. |
pmid:11406265
|
Nakamura M et al. |
Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636600
|
Imamura M et al. |
FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules. |
2000 |
Transplant. Proc. |
pmid:11120238
|
Charco R et al. |
Hypercholesterolemia in long-term survivors of liver transplantation: a comparison between cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636605
|
Jang HJ et al. |
Comparison of pancreas transplantation outcome between the cyclosporine and tacrolimus eras. |
2000 |
Transplant. Proc. |
pmid:11120249
|
Squifflet JP et al. |
The Benelux experience with the combination of tacrolimus and mycophenolate mofetil. |
1999 |
Transplant. Proc. |
pmid:10576050
|
Tekgündüz E et al. |
Electrolyte free water clearance could be an early sign of renal dysfunction in renal transplant patients. |
2009 |
Transplant. Proc. |
pmid:19917375
|
Resch B et al. |
FK 506 and successful pregnancy in a patient after renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9474990
|
Furlan V et al. |
Interaction between tacrolimus and itraconazole in a heart-lung transplant recipient. |
1998 |
Transplant. Proc. |
pmid:9474996
|
Zawiasa A et al. |
Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249511
|
Schwartz M et al. |
FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. The US Multicenter FK 506 Dose Optimization. |
1995 |
Transplant. Proc. |
pmid:7533355
|
de Paulis A et al. |
Antiinflammatory effect of FK 506 on human basophils. |
1991 |
Transplant. Proc. |
pmid:1721309
|
Kuriata-Kordek M et al. |
The influence of calcineurin inhibitors on mycophenolic acid pharmacokinetics. |
2003 |
Transplant. Proc. |
pmid:14529944
|
Wojewodzka J et al. |
Inhibition of formation of synapses between dendritic cells and lymphocytes in skin lymph in an allogeneic reaction by cyclosporine and tacrolimus. |
2003 |
Transplant. Proc. |
pmid:14529947
|
Chiang Y et al. |
Posttransplantation Kaposi sarcoma-experience in a patient receiving FK-506 and MMF. |
2003 |
Transplant. Proc. |
pmid:12591389
|
Suga A et al. |
Diabetes mellitus after renal transplantation under tacrolimus-based immunosuppression. |
2003 |
Transplant. Proc. |
pmid:12591391
|
Borrows R et al. |
Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay. |
2005 |
Transplant. Proc. |
pmid:15919448
|
Koefoed-Nielsen PB et al. |
Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients. |
2005 |
Transplant. Proc. |
pmid:15919449
|
Grochowicz PM et al. |
Synergism of castanospermine and FK 506. |
1995 |
Transplant. Proc. |
pmid:7533408
|
Tamura K et al. |
Inhibition of insulin production by FK 506 is caused at the transcriptional level in pancreatic beta cell when FK BP-12 content is relatively high. |
1995 |
Transplant. Proc. |
pmid:7533409
|
Reding R et al. |
Compassionate use of FK 506 in pediatric liver transplantation: a pilot study. |
1991 |
Transplant. Proc. |
pmid:1721341
|
Lee KK et al. |
Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation. |
1990 |
Transplant. Proc. |
pmid:1702239
|
Uemoto S et al. |
Experience with FK 506 in living related donor liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721342
|
Charco R et al. |
Changes in renal function in long-term survivors of liver transplantation: a comparison between cyclosporine microemulsion and tacrolimus therapy. |
2002 |
Transplant. Proc. |
pmid:12176478
|
Yokoyama I et al. |
Immunosuppressant effect on Fas antigen expression and p53 of an experimental tumor. |
1998 |
Transplant. Proc. |
pmid:9865346
|
Bortman GV et al. |
South American Heart Transplantation Registry of patients receiving everolimus in their immunosuppressive regimens. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172342
|
Strassburg A et al. |
Basiliximab reduces acute liver allograft rejection in pediatric patients. |
2002 |
Transplant. Proc. |
pmid:12270443
|
Rifai K et al. |
Severe hearing loss after liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919504
|
Miller J et al. |
FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123008
|
Kilinç M et al. |
FK 506-induced fulminant leukoencephalopathy after kidney transplantation: case report. |
2002 |
Transplant. Proc. |
pmid:12072309
|
Toyama Y et al. |
Prolonged small bowel graft survival using photochemotherapy and low-dose FK 506. |
1996 |
Transplant. Proc. |
pmid:8907924
|
Takahashi K et al. |
Successful results after 3 years' tacrolimus immunosuppression in ABO-incompatible kidney transplantation recipients in Japan. |
2002 |
Transplant. Proc. |
pmid:12176502
|
Meçule A et al. |
Interleukin-2 profiles shortly after tacrolimus conversion from a twice-daily to once-daily regimen. |
2011 |
Transplant. Proc. |
pmid:21620040
|
Chen CL et al. |
FK 506 used as rescue therapy for refractory liver allograft rejection. |
1994 |
Transplant. Proc. |
pmid:7520612
|
Deuse T et al. |
Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection? |
2007 |
Transplant. Proc. |
pmid:17362784
|
Hebert MF et al. |
Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721373
|
Eiras G et al. |
Effects of FK 506 and cyclosporine on T-cell activation: integrin-mediated adhesion of T cells, proliferation, and maturation of cytotoxic T cells. |
1991 |
Transplant. Proc. |
pmid:1703357
|
Humar A et al. |
Surgical complications requiring early relaparotomy after pancreas transplantation: comparison of the cyclosporine and FK 506 eras. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083256
|
Shapiro R et al. |
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. |
1997 |
Transplant. Proc. |
pmid:9290809
|
Wijnen RM et al. |
Thymus atrophy in the nonhuman primate by FK506: an immunohistochemical study. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123292
|
Kumano K et al. |
Role of the transforming growth factor and monocyte chemoattractant protein in FK506-induced nephropathy in the rat. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123293
|
Bilbao I et al. |
Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377472
|
Braun F et al. |
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus. |
1996 |
Transplant. Proc. |
pmid:8962231
|
Grochowicz PM et al. |
Synergistic interaction between castanospermine and tacrolimus in a rat heart allograft model. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123296
|
van Duijnhoven EM et al. |
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176552
|
Braun F et al. |
Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients. |
2001 |
Transplant. Proc. |
pmid:11377473
|
Wilczek HE et al. |
Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506). |
1996 |
Transplant. Proc. |
pmid:8962232
|
Saito K et al. |
Study of pharmacokinetic parameters of tacrolimus by different oral administration periods in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176553
|
Yussim A et al. |
Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. |
1996 |
Transplant. Proc. |
pmid:8962233
|
Toraishi T et al. |
Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report. |
2012 |
Transplant. Proc. |
pmid:22310597
|
Yoshimura R et al. |
A comparative study of cyclosporine vs FK 506: role of kidney microsomal cytochrome P-450. |
1992 |
Transplant. Proc. |
pmid:1379755
|
Baruch Y et al. |
Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral. |
1996 |
Transplant. Proc. |
pmid:8769215
|
Abu-Elmagd KM et al. |
Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1721404
|
Yamada K et al. |
FK 506-induced juxtaglomerular apparatus hyperplasia and tubular damage in rat kidney--morphologic and biologic analysis. |
1992 |
Transplant. Proc. |
pmid:1379756
|
Melter M et al. |
Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients. |
1996 |
Transplant. Proc. |
pmid:8769224
|
Ishibashi M et al. |
Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay. |
1989 |
Transplant. Proc. |
pmid:2469228
|
Ettenger R |
The practical problems of prednisone in pediatric renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267159
|
Takahashi Y et al. |
Pharmacokinetic Profile of Twice- and Once-daily Tacrolimus in Pediatric Kidney Transplant Recipients. |
|
Transplant. Proc. |
pmid:28104153
|
Boletis J et al. |
Delayed renal graft function: the influence of immunosuppression. |
2005 |
Transplant. Proc. |
pmid:15964337
|
Reggiani P et al. |
Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9723308
|
Levy GA |
Neoral use in the liver transplant recipient. |
2000 |
Transplant. Proc. |
pmid:10814745
|
Lauro A et al. |
Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning? |
2005 |
Transplant. Proc. |
pmid:15964382
|
Russ GR et al. |
Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients. |
2003 |
Transplant. Proc. |
pmid:12742480
|
Ciancio G et al. |
Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176637
|
El-Sabrout R et al. |
Improved lipid profile and blood sugar control in pediatric renal transplant recipients using sirolimus-tacrolimus combination. |
2002 |
Transplant. Proc. |
pmid:12176638
|
Doesch AO et al. |
Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. |
2010 |
Transplant. Proc. |
pmid:21168673
|
Moray G et al. |
Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin in living-donor liver transplantation. |
2006 |
Transplant. Proc. |
pmid:17175334
|
Rayhill SC et al. |
A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. |
2006 |
Transplant. Proc. |
pmid:17175350
|
Kuroki H et al. |
Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721436
|
Ito T et al. |
Bone marrow cell- and FK 506-induced donor-specific unresponsiveness in rat heart allografts. |
1991 |
Transplant. Proc. |
pmid:1721437
|
Todo S et al. |
Orthotopic liver transplantation in dogs receiving FK-506. |
1987 |
Transplant. Proc. |
pmid:2445079
|
Lim SM et al. |
Heterotopic heart transplantation in the rat receiving FK-506. |
1987 |
Transplant. Proc. |
pmid:2445080
|
Jain A et al. |
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267319
|
Mueller AR et al. |
Influence of immunosuppression on patient survival after liver transplantation for hepatitis C. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267321
|
Krämer BK et al. |
Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials. |
2017 |
Transplant. Proc. |
pmid:29149958
|
Cofan F et al. |
Fatty acid composition in low-density lipoproteins from renal transplant recipients. |
1999 |
Transplant. Proc. |
pmid:10500603
|
Alvarez-ElÃas AC et al. |
CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children. |
2016 |
Transplant. Proc. |
pmid:27110018
|
Hashi S et al. |
Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. |
2014 |
Transplant. Proc. |
pmid:24767342
|
Uemoto S et al. |
Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan. |
2014 |
Transplant. Proc. |
pmid:24767340
|
GarcÃa-Bello JA et al. |
Effect of Immunosuppressive Therapy on Cardiovascular Risk Factor Prevalence in Kidney-Transplanted Children: Comparative Study. |
2016 |
Transplant. Proc. |
pmid:27110020
|
Braun F et al. |
Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636496
|
Tanabe K et al. |
Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636497
|
Stratta RJ et al. |
Preliminary experience with FK 506 in pancreas transplant recipients. |
1995 |
Transplant. Proc. |
pmid:8539823
|